• Specification: 0.4g*3 tablets, 6 tablets
• Indications: Moxifloxacin is indicated for the treatment of adults (≥18 years old) with upper and lower respiratory tract infections, such as acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, and skin and soft tissue infections.
• Access information: Prescription drug
• Manufacturer: Hunan Tianji Caotang Pharmaceutical Co., Ltd.